Does SIMPONI Cause Interstitial lung disease? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Interstitial lung disease have been filed in association with SIMPONI. This represents 1.6% of all adverse event reports for SIMPONI.
11
Reports of Interstitial lung disease with SIMPONI
1.6%
of all SIMPONI reports
2
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From SIMPONI?
Of the 11 reports, 2 (18.2%) resulted in death, 5 (45.5%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMPONI. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does SIMPONI Cause?
Pneumonia (50)
Drug ineffective (36)
Device malfunction (29)
Drug dose omission (26)
Pain (24)
Diarrhoea (21)
Rheumatoid arthritis (20)
Vomiting (20)
Fall (18)
Malaise (18)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SIMPONI Alternatives Have Lower Interstitial lung disease Risk?
SIMPONI vs SIMVASTATIN
SIMPONI vs SINGULAIR
SIMPONI vs SINTILIMAB
SIMPONI vs SIPONIMOD
SIMPONI vs SIPULEUCEL-T